ClinicalTrials.Veeva

Menu

Physiological Effects Ketone Ester in Heart (KEHeart)

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Active, not recruiting

Conditions

Heart Failure

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Ketone Ester

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study is aimed to phenotype with cardiac MRI the physiological effects of ketone esters on the heart. Patients with heart failure will be recruited and given ketone esters or placebo in a randomized fashion. Cardiac MRI will be performed at baseline and after 12weeks follow up.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • heart failure EF < 40%

Exclusion criteria

  • Claustrophobia
  • Contraindicated implanted device

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Placebo given that mimics taste, weight, and size of the interventional supplement mirroring the same time points as the ketone ester supplement group. Mirrored imaging with MRI as well.
Treatment:
Dietary Supplement: Placebo
Ketone ester supplement
Experimental group
Description:
Ketone ester given daily for 12 weeks and scanned before and after intervention with MRI.
Treatment:
Dietary Supplement: Ketone Ester

Trial contacts and locations

1

Loading...

Central trial contact

Jessica Lee; Christopher Nguyen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems